Patents by Inventor Jean-Louis Reber

Jean-Louis Reber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINOLINONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS
    Publication number: 20120316142
    Abstract: Compounds of formula I in salt or solvate form, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 and A have the meanings as indicated in the specification, are useful for treating diseases mediated by the ?2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: May 4, 2012
    Publication date: December 13, 2012
    Inventors: Olivier LOHSE, Stéphanie MONNIER, Jean-Louis REBER
  • Organic Compounds
    Publication number: 20120208882
    Abstract: The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
    Type: Application
    Filed: February 14, 2012
    Publication date: August 16, 2012
    Inventors: Henry Luke Danahay, Darren Mark LeGrand, David C. Tully, Jennifer Leslie Harris, Silvia Heuerding, Dilraj Singh, Janet Catherine Maas, Juergen Roettele, Jean-Louis Reber, Stéphanie Monnier
  • Quinolinone derivatives and their pharmaceutical compositions
    Patent number: 8198450
    Abstract: Compounds of formula I in salt or solvate form, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 and A have the meanings as indicated in the specification, are useful for treating diseases mediated by the ?2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Grant
    Filed: July 2, 2007
    Date of Patent: June 12, 2012
    Assignee: Novartis AG
    Inventors: Olivier Lohse, Stephanie Monnier, Jean-Louis Reber
  • SALT AND POLYMORPHS OF A KINESIN INHIBITOR COMPOUND
    Publication number: 20110275685
    Abstract: The present invention relates to salts, polymorphs and hydrates of the kinesin inhibitor compound N-((S)-3-amino-4-fluorobutyl)-N-((R)-1-(1-benzlyl-4-(2,5-difluorophenyl)-1H-imidazol-2-yl)-2,2-dimethylpropyl)-2-hydroxyacetamide, processes to prepare such salts, polymorphs and hydrates and a liquid formulation comprising at least one of these salts, polymorphs and hydrates.
    Type: Application
    Filed: January 25, 2010
    Publication date: November 10, 2011
    Inventors: Michael Mutz, Jean-Louis Reber, Stephanie Monnier
  • SALT OF ALISKIREN WITH OROTIC ACID
    Publication number: 20100130616
    Abstract: The invention relates to a new salt of aliskiren, the respective production and usage, and pharmaceutical preparations containing such a salt.
    Type: Application
    Filed: November 7, 2007
    Publication date: May 27, 2010
    Applicant: NOVARTIS AG
    Inventors: Jean Louis Reber, Frank Stowasser
  • QUINOLINONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS
    Publication number: 20090325912
    Abstract: Compounds of formula I in salt or solvate form, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 and A have the meanings as indicated in the specification, are useful for treating diseases mediated by the ?2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: July 2, 2007
    Publication date: December 31, 2009
    Inventors: Olivier Lohse, Stéphanie Monnier, Jean-Louis Reber
  • ORGANIC COMPOUNDS
    Publication number: 20090203777
    Abstract: The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
    Type: Application
    Filed: April 12, 2006
    Publication date: August 13, 2009
    Inventors: Henry Luke Danahay, Darren Mark Legrand, David C. Tully, Jennifer Leslie Harris, Silvia Heuerding, Dilraj Singh, Janet Catherine Maas, Juergen Roettele, Jean-Louis Reber, Stephanie Monnier
  • Malic acid addition salts of terbinafine
    Patent number: 7488759
    Abstract: The invention concerns salts of the compound of formula I with malic acid, their preparation, corresponding pharmaceutical compositions and their use as antimycotics.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: February 10, 2009
    Assignee: Novartis AG
    Inventors: Danielle Giron, Jean-Louis Reber, Stefan Hirsch
  • Compounds
    Publication number: 20080279932
    Abstract: The present invention relates to novel salt forms of vildagliptin (LAF237), i.e. salt forms of(S)-1-[(3-hydroxy-1-adamantyl)amino]acetyl-2-cyano-pyrrolidine.
    Type: Application
    Filed: August 2, 2006
    Publication date: November 13, 2008
    Inventors: Jean-Louis Reber, Edwin Bernard Villhauer
  • Malic acid addition salts of terbinafine
    Publication number: 20070088084
    Abstract: The invention concerns salts of the compound of formula I with malic acid, their preparation, corresponding pharmaceutical compositions and their use as antimycotics.
    Type: Application
    Filed: November 29, 2006
    Publication date: April 19, 2007
    Inventors: Danielle Giron, Jean-Louis Reber, Stefan Hirsch
  • Malic acid addition salts of terbinafine
    Publication number: 20040147603
    Abstract: The invention concerns salts of the compound of formula I 1
    Type: Application
    Filed: February 18, 2004
    Publication date: July 29, 2004
    Inventors: Danielle Giron, Jean-Louis Reber, Stefan Hirsch